Revolutionizing pharmaceutical development
12
Revolutionizing pharmaceutical development by Lilien Cheminformatics University of Toronto, December 2009 [email protected] 1
description
Revolutionizing pharmaceutical development. by Lilien Cheminformatics University of Toronto, December 2009 S [email protected]. University of Toronto, December 2009 . Chemists use pen & paper to generate reaction plans for target molecule . - PowerPoint PPT Presentation
Transcript of Revolutionizing pharmaceutical development
Revolutionizing pharmaceutical development
by Lilien CheminformaticsUniversity of Toronto, December [email protected]
1
University of Toronto, December 2009
Chemists use pen & paper to generate reaction plans for target molecule.
...over 100 million chemical substances and sequences! 2
The SolutionAutomate Planning
Reduce scale-up time from 2 yrs to 2 months
Extended patent protection
Discover new reaction pathways.University of Toronto, December 2009 3
University of Toronto, December 2009 4Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009
BUSINESS MODEL CANVASInfrastructure Customer
Finance
University of Toronto, December 2009 4
Infrastructure
Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009
BUSINESS MODEL CANVAS
Key ActivitiesPartner Network
Key Resources
R&D
Experts in chemistry & technology.
Academia
Reaction DB
Education
& Training
Publishing Companies
Customer
Finance
University of Toronto, December 2009 4
CustomerInfrastructure
Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009
BUSINESS MODEL CANVAS
Key ActivitiesPartner Network
Key Resources
R&D
Experts in chemistry & technology.
Academia
Reaction DB
Education
& Training
Publishing Companies
Pharmaceutical companies
Distribution Channel
Training, Support
Reaction DB updates
Website with
cd/dvds of products
Networking within
Universities
Finance
Finance
University of Toronto, December 2009 4
CustomerInfrastructure
Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009
BUSINESS MODEL CANVAS
Key ActivitiesPartner Network
Key Resources
R&D
Experts in chemistry & technology.
Academia
Reaction DB
Education
& Training
Publishing Companies
Pharmaceutical companies
Distribution Channel
Training, Support
Reaction DB updates
Website with
cd/dvds of products
Networking within
Universities
Cost Structure Revenue Streams
Yearly Licensing
ModelSupport
Maintenance
Staff
R&D
Marketing
University of Toronto, December 2009
Competition
5
Efficien
cy
Completeness
ARChem
Theresa
SynChem
LHASA
University of Toronto, December 2009
The Magic
6
Expertise Over 10 years of research
Partners Close relations industry
contacts
Opportunity Increasing cost Decreased drug approval
University of Toronto, December 2009
The Team
Peter Park, CEO
Brian Keng, CFO
Dejana Bajic, VP Sales and Marketing
Maryah Safi, VP Product Development
Amanda Manarin, Sales and Finance
7
University of Toronto, December 2009 8
Total Operating Costs Total Revenue
Net Earnings
$(5,000)
$-
$5,000
$10,000
$15,000
$20,000
$25,000
$30,000
Revenues
Costs
Net Earnings
Cash Flow
Timeline
Mon
tly I
ncom
e +
Cash
Flo
w in
$
10
00
s
Year 1 Year 2 Year 3 Year 4 Year 5
University of Toronto, December 2009
How you can help
Invest $1.2 million: Alpha release of product Covers cash flow for first year Establish contacts with phamas
9
